US Stock MarketDetailed Quotes

ABUS Arbutus Biopharma

Watchlist
  • 3.290
  • -0.010-0.30%
Close Feb 14 16:00 ET
  • 3.210
  • -0.080-2.43%
Post 20:01 ET
623.43MMarket Cap-7.65P/E (TTM)

Arbutus Biopharma Key Stats

Arbutus Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.971M--
--2024/Q4-- / 2.198M--
Nov 6, 20242024/Q31.855M / 2.573M--
Aug 1, 20242024/Q22.390M / 2.415M--
May 2, 20242024/Q12.108M / 3.682M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.971M--
--2024/Q4-- / 2.198M--
Nov 6, 20242024/Q31.855M / 2.573M--
Aug 1, 20242024/Q22.390M / 2.415M--
May 2, 20242024/Q12.108M / 3.682M--

Unlock Free Earnings Estimates

Arbutus Biopharma Earnings Reports

Read more

Trending Stocks

Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.